StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) stock

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

What it earns on the capital it uses

Trailing twelve months over average capital

Return on capital employed-191.0%vs -17.2%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by C$21.42M. That is 21.0% of the C$101.87M it would cost to buy the business outright.

Cash and short-term investmentsC$21.42M
EBITDA, trailing twelve months-C$34.32M
Free cash flow, trailing twelve months-C$23.88M

Leverage and liquidity

Current ratio4.16vs 2.65
Quick ratio3.80vs 1.46

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

-3.63
DistressGrey zoneSafe

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Free cash flow yield-19.4%vs -19.4%
Buyback yield-13.0%vs -12.4%
Shareholder yield-13.0%vs -12.4%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 20, 2026

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

26
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

CRDLS&P 500
PeriodCRDLS&P 500DifferenceCRDL per yearS&P 500 per year
1 month-25.0%-10.3%−14.7 pts
3 months-54.2%-9.3%−44.9 pts
Year to date-9.6%+1.9%−11.5 pts
1 year-10.6%+6.9%−17.5 pts
3 years+0.2%+57.5%−57.3 pts+0.1%+16.3%
5 years-57.9%+57.3%−115.2 pts-15.9%+9.5%

How much it moves

Beta against the S&P 5001.19vs 1.27
Volatility, 1 year62.3%vs 83.6%
Volume against its 90-day average0.46vs 1.28

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M CRDL shares were sold short on Oct 30, 2026, down 8.7% from the previous report. At recent volumes it would take 4.3 days to buy them back. Over the last 20 sessions, 39.6% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Days of volume to buy it back4.27vs 7.10

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20262,596,228-8.7%608,1634.3
Oct 15, 20262,844,557-7.4%2,185,2511.3
Sep 30, 20263,071,971-7.3%984,5923.1
Sep 15, 20263,312,998+13.2%1,504,2112.2
Aug 31, 20262,927,585+26.7%1,785,7721.6
Aug 14, 20262,311,371+2.6%1,127,1802.0
Jul 31, 20262,252,735+1.9%982,3432.3
Jul 15, 20262,210,924-0.3%814,8262.7
Jun 30, 20262,217,703+6.4%340,0666.5
Jun 15, 20262,084,149+8.6%397,8955.2
May 29, 20261,918,255-2.1%297,9006.4
May 15, 20261,958,996-0.3%439,4134.5

Every measure, in full

44 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Dec 31, 2025
Share price as of
–

Valuation ratiosIndustry

Market Cap
C$123.29M
C$215.78M
Enterprise Value
C$101.87M
C$150.13M

Share statisticsIndustry

Shares Change (YoY)
21.5%
18.0%
Float
79M
74M
Shares Held by Insiders
21.3%
0.00%
Shares Held by Institutions
29.4%
12.2%

Short sellingIndustry

Short Interest
3M
–
Short Interest Change
-8.73%
-1.74%
Days to Cover
4.27
7.10

Stock price statisticsIndustry

Price Change (1 Week)
-13.7%
-19.1%
Price Change (1 Month)
-25.0%
-31.3%
Price Change (3 Months)
-53.6%
-53.7%
Price Change (6 Months)
-34.7%
-52.4%
Price Change (YTD)
-9.56%
-62.5%
Price Change (1 Year)
-13.4%
-60.4%
Price Change (3 Years)
2.67%
-52.6%
Price Change (5 Years)
-57.9%
-89.1%
Average Volume (10 Days)
455,265
–
Average Volume (20 Days)
523,945
–
Average Volume (90 Days)
1M
–
Relative Volume
0.46
1.28
Relative Strength Index (14)
25.6
28.1
Volatility (1 Year)
62.3%
83.6%
Beta (5 Years)
1.19
1.27

Returns on capitalIndustry

Return on Capital Employed (ROCE)
-191.0%
-17.2%

Financial positionIndustry

Current Ratio
4.16
2.65
Quick Ratio
3.80
1.46

EfficiencyIndustry

WACC
11.0%
11.4%

Income statement (TTM)Industry

Operating Income
-C$34.32M
-C$16.55M
EBITDA
-C$34.32M
-C$16.37M
EPS (Diluted)
-0.39 CAD
-0.19 CAD

Balance sheetIndustry

Net Cash (Debt)
C$21.42M
C$27.83M
Net Cash Per Share
0.21 CAD
0.25 CAD
Working Capital
C$17.85M
C$25.22M

Cash flow (TTM)Industry

Operating Cash Flow
-C$23.85M
-C$8.69M
Capital Expenditures
-C$24.48K
-C$510.54K
Free Cash Flow
-C$23.88M
-C$11.52M
FCF Per Share
-0.24 CAD
-0.07 CAD

Dividends and yieldsIndustry

FCF Yield
-19.4%
-19.4%
Buyback Yield
-13.0%
-12.4%
Shareholder Yield
-13.0%
-12.4%

Scores and fair valueIndustry

Altman Z-Score
-3.63
-1.03

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?